India · Delayed Price · Currency is INR Morepen Laboratories Statistics
Total Valuation
NSE:MOREPENLAB has a market cap or net worth of INR 25.58 billion. The enterprise value is 25.67 billion.
| Market Cap | 25.58B |
| Enterprise Value | 25.67B |
Important Dates
The last earnings date was Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Aug 29, 2025 |
Share Statistics
| Current Share Class | 547.95M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.07% |
| Shares Change (QoQ) | -7.41% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 307.37M |
Valuation Ratios
The trailing PE ratio is 27.63.
| PE Ratio | 27.63 |
| Forward PE | n/a |
| PS Ratio | 1.42 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 27.72 |
| EV / Sales | 1.43 |
| EV / EBITDA | 15.52 |
| EV / EBIT | 19.20 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.64 |
| Debt / FCF | n/a |
| Interest Coverage | 11.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.71% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.37M |
| Profits Per Employee | 430,301 |
| Employee Count | 2,152 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:MOREPENLAB has paid 292.06 million in taxes.
| Income Tax | 292.06M |
| Effective Tax Rate | 23.85% |
Stock Price Statistics
The stock price has decreased by -19.77% in the last 52 weeks. The beta is 0.79, so NSE:MOREPENLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -19.77% |
| 50-Day Moving Average | 60.98 |
| 200-Day Moving Average | 64.06 |
| Relative Strength Index (RSI) | 15.59 |
| Average Volume (20 Days) | 3,339,482 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MOREPENLAB had revenue of INR 18.01 billion and earned 926.01 million in profits. Earnings per share was 1.70.
| Revenue | 18.01B |
| Gross Profit | 6.20B |
| Operating Income | 1.34B |
| Pretax Income | 1.22B |
| Net Income | 926.01M |
| EBITDA | 1.65B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | 1.70 |
Balance Sheet
The company has 1.27 billion in cash and 1.05 billion in debt, giving a net cash position of 220.72 million.
| Cash & Cash Equivalents | 1.27B |
| Total Debt | 1.05B |
| Net Cash | 220.72M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.87B |
| Book Value Per Share | 19.92 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 34.44%, with operating and profit margins of 7.42% and 5.14%.
| Gross Margin | 34.44% |
| Operating Margin | 7.42% |
| Pretax Margin | 6.80% |
| Profit Margin | 5.14% |
| EBITDA Margin | 9.19% |
| EBIT Margin | 7.42% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.43%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.43% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.07% |
| Shareholder Yield | -5.64% |
| Earnings Yield | 3.62% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 6, 2000. It was a forward split with a ratio of 5.
| Last Split Date | Nov 6, 2000 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |